Bank of America’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117M Buy
220,720
+8,537
+4% +$3.94M 0.01% 1079
2026
Q1
$102M Buy
212,183
+1,487
+0.7% +$761K 0.01% 1101
2025
Q4
$118M Sell
210,696
-18,657
-8% -$10.6M 0.01% 1004
2025
Q3
$118M Buy
229,353
+39,389
+21% +$17.2M 0.01% 1104
2025
Q2
$59.6M Buy
189,964
+8,342
+5% +$2.5M ﹤0.01% 1546
2025
Q1
$55.3M Buy
181,622
+40,547
+29% +$13.6M ﹤0.01% 1496
2024
Q4
$46.9M Sell
141,075
-26,775
-16% -$9.08M ﹤0.01% 1552
2024
Q3
$56M Buy
167,850
+17,852
+12% +$6.78M ﹤0.01% 1475
2024
Q2
$61.8M Buy
149,998
+6,270
+4% +$2.48M 0.01% 1319
2024
Q1
$58.1M Buy
143,728
+7,678
+6% +$2.7M 0.01% 1371
2023
Q4
$41.7M Sell
136,050
-9,674
-7% -$2.61M ﹤0.01% 1499
2023
Q3
$35.3M Sell
145,724
-37,863
-21% -$9.68M ﹤0.01% 1530
2023
Q2
$44.1M Buy
183,587
+14,945
+9% +$3.1M ﹤0.01% 1403
2023
Q1
$31.7M Buy
168,642
+5,477
+3% +$1.13M ﹤0.01% 1724
2022
Q4
$34.7M Buy
163,165
+1,060
+0.7% +$212K ﹤0.01% 1568
2022
Q3
$25.5M Buy
162,105
+5,240
+3% +$836K ﹤0.01% 1757
2022
Q2
$23.5M Buy
156,865
+1,737
+1% +$251K ﹤0.01% 1864
2022
Q1
$25.4M Buy
155,128
+3,914
+3% +$645K ﹤0.01% 1919
2021
Q4
$32.9M Sell
151,214
-8,481
-5% -$1.78M ﹤0.01% 1743
2021
Q3
$30.2M Buy
159,695
+26,574
+20% +$4.85M ﹤0.01% 1774
2021
Q2
$23.5M Buy
133,121
+2,124
+2% +$367K ﹤0.01% 1993
2021
Q1
$21.5M Buy
130,997
+140
+0.1% +$21.4K ﹤0.01% 1970
2020
Q4
$18.2M Buy
130,857
+26,981
+26% +$3.4M ﹤0.01% 1982
2020
Q3
$11.6M Sell
103,876
-25,221
-20% -$2.92M ﹤0.01% 2161
2020
Q2
$12M Sell
129,097
-10,165
-7% -$865K ﹤0.01% 2046
2020
Q1
$10.2M Sell
139,262
-13,184
-9% -$1.14M ﹤0.01% 2049
2019
Q4
$12.8M Sell
152,446
-9,203
-6% -$712K ﹤0.01% 2317
2019
Q3
$13.6M Sell
161,649
-85,043
-34% -$6.43M ﹤0.01% 2200
2019
Q2
$16.1M Sell
246,692
-59,244
-19% -$3.41M ﹤0.01% 2065
2019
Q1
$18M Buy
305,936
+66,761
+28% +$3.99M ﹤0.01% 1919
2018
Q4
$12.7M Sell
239,175
-35,282
-13% -$1.94M ﹤0.01% 2068
2018
Q3
$16.4M Buy
274,457
+25,475
+10% +$1.39M ﹤0.01% 2011
2018
Q2
$10.7M Buy
248,982
+212,673
+586% +$8.59M ﹤0.01% 2387
2018
Q1
$1.27M Buy
36,309
+3,267
+10% +$119K ﹤0.01% 4228
2017
Q4
$1.2M Buy
33,042
+26,182
+382% +$918K ﹤0.01% 4363
2017
Q3
$219K Buy
6,860
+2,931
+75% +$89.5K ﹤0.01% 5344
2017
Q2
$113K Buy
3,929
+2,485
+172% +$69.7K ﹤0.01% 5569
2017
Q1
$43K Sell
1,444
-21,889
-94% -$706K ﹤0.01% 5995
2016
Q4
$841K Buy
+23,333
New +$777K ﹤0.01% 4472

Other funds holding MEDP

Bank of America's MEDP Position: Q2 2026 in Review

Bank of America increased its Medpace (MEDP) stake by 4% in Q2 2026, buying an estimated $3.94M and bringing the position to 220,720 shares worth $117M. The position accounts for 0.01% of the portfolio, ranked #1079.

Bank of America first reported a position in MEDP in Q4 2016 and has held it in 39 quarters since. The position peaked at $118M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bank of America held 220,720 shares of Medpace worth $117M as of Q2 2026.
  • Bank of America bought 8,537 Medpace shares in Q2 2026, an estimated $3.94M.
  • Medpace made up 0.01% of Bank of America's portfolio in Q2 2026, its #1079 holding.
  • Bank of America first reported a position in Medpace in Q4 2016 and has held it in 39 quarters since.
  • Bank of America's Medpace position peaked at $118M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.